SMTL ID : 6ic7.1

Human cathepsin-C in complex with dipeptidyl cyclopropyl nitrile inhibitor 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-4-4-4-mer

Ligands

4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.1: 4 residues within 4Å: Chain A: Y.93, N.95, E.96, K.116 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.6: 4 residues within 4Å: Chain D: Y.93, N.95, E.96, K.116 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-MAN-MAN.11: 4 residues within 4Å: Chain G: Y.93, N.95, E.96, K.116 1 PLIP interactions: 1 interactions with chain G Hydrogen bonds: G:Y.93 NAG-NAG-BMA-MAN-MAN.16: 4 residues within 4Å: Chain J: Y.93, N.95, E.96, K.116 1 PLIP interactions: 1 interactions with chain J Hydrogen bonds: J:Y.93

8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 4 residues within 4Å: Chain A: N.5, N.65 Chain C: F.6, L.8 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.65 NAG.3: 5 residues within 4Å: Chain B: N.47 Chain D: L.54 Chain K: H.1, L.2, T.4 5 PLIP interactions: 1 interactions with chain B, 3 interactions with chain K, 1 interactions with chain D Hydrogen bonds: B:N.47, K:T.4, K:T.4 Hydrophobic interactions: K:T.4, D:L.54 NAG.7: 4 residues within 4Å: Chain D: N.5, N.65 Chain F: F.6, L.8 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.65 NAG.8: 5 residues within 4Å: Chain A: L.54 Chain E: N.47 Chain H: H.1, L.2, T.4 5 PLIP interactions: 1 interactions with chain E, 3 interactions with chain H, 1 interactions with chain A Hydrogen bonds: E:N.47, H:T.4, H:T.4 Hydrophobic interactions: H:T.4, A:L.54 NAG.12: 4 residues within 4Å: Chain G: N.5, N.65 Chain I: F.6, L.8 1 PLIP interactions: 1 interactions with chain G Hydrogen bonds: G:N.65 NAG.13: 5 residues within 4Å: Chain E: H.1, L.2, T.4 Chain H: N.47 Chain J: L.54 4 PLIP interactions: 1 interactions with chain H, 2 interactions with chain E, 1 interactions with chain J Hydrogen bonds: H:N.47, E:T.4 Hydrophobic interactions: E:T.4, J:L.54 NAG.17: 4 residues within 4Å: Chain J: N.5, N.65 Chain L: F.6, L.8 1 PLIP interactions: 1 interactions with chain J Hydrogen bonds: J:N.65 NAG.18: 5 residues within 4Å: Chain B: H.1, L.2, T.4 Chain G: L.54 Chain K: N.47 4 PLIP interactions: 1 interactions with chain K, 2 interactions with chain B, 1 interactions with chain G Hydrogen bonds: K:N.47, B:T.4 Hydrophobic interactions: B:T.4, G:L.54

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 6 residues within 4Å: Chain B: F.73, P.74, Y.75, Y.118 Chain C: I.59, V.61 Ligand excluded by PLIP CL.9: 6 residues within 4Å: Chain E: F.73, P.74, Y.75, Y.118 Chain F: I.59, V.61 Ligand excluded by PLIP CL.14: 6 residues within 4Å: Chain H: F.73, P.74, Y.75, Y.118 Chain I: I.59, V.61 Ligand excluded by PLIP CL.19: 6 residues within 4Å: Chain K: F.73, P.74, Y.75, Y.118 Chain L: I.59, V.61 Ligand excluded by PLIP

4 x H9H: 1-azanyl-~{N}-[(1~{R},2~{R})-1-cyano-2-[4-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]phenyl]cyclopropyl]cyclohexane-1-carboxamide(Non-covalent)

H9H.5: 15 residues within 4Å: Chain A: D.1, T.2, P.3 Chain B: Q.23, G.27, S.28, C.29, Y.30, E.70, G.71, G.72, F.73, A.144 Chain C: T.9, N.10 9 PLIP interactions: 7 interactions with chain B, 1 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: B:F.73, B:F.73, B:A.144, A:D.1 Hydrogen bonds: B:Q.23, B:C.29, B:G.72, B:G.72, C:N.10 H9H.10: 15 residues within 4Å: Chain D: D.1, T.2, P.3 Chain E: Q.23, G.27, S.28, C.29, Y.30, E.70, G.71, G.72, F.73, A.144 Chain F: T.9, N.10 9 PLIP interactions: 7 interactions with chain E, 1 interactions with chain D, 1 interactions with chain F Hydrophobic interactions: E:F.73, E:F.73, E:A.144, D:D.1 Hydrogen bonds: E:Q.23, E:C.29, E:G.72, E:G.72, F:N.10 H9H.15: 15 residues within 4Å: Chain G: D.1, T.2, P.3 Chain H: Q.23, G.27, S.28, C.29, Y.30, E.70, G.71, G.72, F.73, A.144 Chain I: T.9, N.10 9 PLIP interactions: 7 interactions with chain H, 1 interactions with chain I, 1 interactions with chain G Hydrophobic interactions: H:F.73, H:F.73, H:A.144, G:D.1 Hydrogen bonds: H:Q.23, H:C.29, H:G.72, H:G.72, I:N.10 H9H.20: 15 residues within 4Å: Chain J: D.1, T.2, P.3 Chain K: Q.23, G.27, S.28, C.29, Y.30, E.70, G.71, G.72, F.73, A.144 Chain L: T.9, N.10 9 PLIP interactions: 7 interactions with chain K, 1 interactions with chain J, 1 interactions with chain L Hydrophobic interactions: K:F.73, K:F.73, K:A.144, J:D.1 Hydrogen bonds: K:Q.23, K:C.29, K:G.72, K:G.72, L:N.10

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Korkmaz, B. et al., Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C. Biochem. Pharmacol. (2019)

Release Date

2019-04-24

Peptides

Dipeptidyl peptidase 1: ADGJ
Dipeptidyl peptidase 1: BEHK
Dipeptidyl peptidase 1: CFIL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
A

G
A

J
A

B
B

E
B

H
B

K
B

C
C

F
C

I
C

L
C

Dipeptidyl peptidase 1

Dipeptidyl peptidase 1

Dipeptidyl peptidase 1

Related Entries With Identical Sequence